Eagle Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-284,539
Closed -$91.2M 603
2024
Q1
$91.2M Sell
284,539
-3,443
-1% -$845K 0.46% 85
2023
Q4
$54.9M Sell
287,982
-43,469
-13% -$8.22M 0.29% 121
2023
Q3
$66M Sell
331,451
-49,165
-13% -$11.6M 0.39% 98
2023
Q2
$109M Buy
380,616
+308,622
+429% +$85.7M 0.61% 58
2023
Q1
$15.6M Sell
71,994
-20,653
-22% -$4.02M 0.09% 189
2022
Q4
$17.8M Sell
92,647
-48,075
-34% -$12.2M 0.11% 180
2022
Q3
$39.1M Buy
140,722
+42,700
+44% +$10.9M 0.26% 127
2022
Q2
$18.7M Buy
98,022
+5,647
+6% +$997K 0.12% 181
2022
Q1
$19.2M Buy
+92,375
New +$15.2M 0.1% 204

Other funds holding SWAV

Eagle Asset Management's SWAV Position: Q2 2024 in Review

Eagle Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 284,539 shares — an estimated $91.2M sold.

Eagle Asset Management first reported a position in SWAV in Q1 2022 and held it in 9 quarters. The position peaked at $109M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Eagle Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Eagle Asset Management sold 284,539 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $91.2M.
  • Eagle Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • Eagle Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $109M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Eagle Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.